Jane Street
RLMD icon

Jane Street’s Relmada Therapeutics RLMD Stock Holding History

Jane Street’s Portfolio RLMD Stock Details RLMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.54M Sell
221,969
-49,140
-18% -$232K ﹤0.01% 5577
2025
Q4 		$1.31M Buy
271,109
+185,442
+216% +$621K ﹤0.01% 5594
2025
Q3 		$172K Sell
85,667
-28,687
-25% -$27.5K ﹤0.01% 9783
2025
Q2 		$68.6K Buy
+114,354
New +$58.7K ﹤0.01% 9095
2024
Q3 		– Sell
-37,476
Closed -$112K – 10284
2024
Q2 		$112K Sell
37,476
-137,753
-79% -$498K ﹤0.01% 8684
2024
Q1 		$815K Buy
175,229
+163,094
+1,344% +$786K ﹤0.01% 5773
2023
Q4 		$50.2K Buy
+12,135
New +$35.9K ﹤0.01% 8777
2023
Q3 		– Sell
-12,118
Closed -$29.8K – 9264
2023
Q2 		$29.8K Buy
+12,118
New +$33.5K ﹤0.01% 8309
2023
Q1 		– Sell
-118,583
Closed -$414K – 9780
2022
Q4 		$414K Buy
+118,583
New +$1.04M ﹤0.01% 6466
2022
Q3 		– Sell
-12,348
Closed -$342K – 10335
2022
Q2 		$234K Sell
12,348
-43,395
-78% -$947K ﹤0.01% 7972
2022
Q1 		$1.5M Buy
+55,743
New +$1.15M ﹤0.01% 5288
2021
Q3 		– Sell
-18,919
Closed -$606K – 10595
2021
Q2 		$606K Buy
+18,919
New +$657K ﹤0.01% 6881
2020
Q3 		– Sell
-18,698
Closed -$836K – 7799
2020
Q2 		$836K Buy
18,698
+10,762
+136% +$455K ﹤0.01% 4324
2020
Q1 		$271K Buy
+7,936
New +$320K ﹤0.01% 4321

Other funds holding RLMD

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
SSC
Spruce Street Capital New York $416M AUM
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Jane Street's RLMD Position: Q1 2026 in Review

Jane Street reduced its Relmada Therapeutics (RLMD) stake by 18% in Q1 2026, selling an estimated $232K and leaving 221,969 shares worth $1.54M. The position accounts for ﹤0.01% of the portfolio, ranked #5577.

Jane Street first reported a position in RLMD in Q1 2020 and has held it in 14 quarters since. 103 funds tracked by Wall St. Rank hold RLMD as of Q1 2026.

  • Jane Street held 221,969 shares of Relmada Therapeutics worth $1.54M as of Q1 2026.
  • Jane Street sold 49,140 Relmada Therapeutics shares in Q1 2026, an estimated $232K.
  • Relmada Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #5577 holding.
  • Jane Street first reported a position in Relmada Therapeutics in Q1 2020 and has held it in 14 quarters since.
  • 103 funds tracked by Wall St. Rank held Relmada Therapeutics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.